Clinical Trial Update: Molecularly Tailored Therapy for Pancreas Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial on molecularly tailored therapy for pancreatic cancer has completed. The update does not provide efficacy results in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Georgetown University | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED